Research > ETFs > ETF / ETP Commentary > 

OUSM ETF Rebalances: Highlighting Quality Factor Shifts

The index underpinning the ALPS O’Shares U.S. Small-Cap Quality Dividend ETF (OUSM A) recently completed its annual reconstitution on September 18. Small-cap equities continue to navigate persistent macroeconomic shifts and higher interest rates. In this environment, index rebalances provide insight into where balance-sheet health, profitability, and cash-flow reliability are strengthening.Key Takeaways: The ALPS O’Shares U.S. Small-Cap Quality Dividend ETF (OUSM A) completed its annual reconstitution, making 28 additions and 26 deletions. Rebalance actions signaled a distinct rotation away from consumer staples and toward high-cash-flow healthcare, technology, and industrial names. The index added healthcare leaders Concentra Group Holdings Parent Inc (CON) and Universal Health Services Inc (UHS) at top weightings while trimming leverage-sensitive holdings. Rebalance Rotates Exposure Toward Quality Healthcare & TechOUSM is based on the O’Shares U.S. Small-Cap Quality Dividend Index, which screens the small-cap universe using a disciplined multi-factor model centered on quality, volatility, dividend yield, and dividend quality. The methodology keeps the portfolio firmly grounded in financial stability by excluding businesses burdened with high debt or declining earnings quality. OUSM has a portfolio of 111 holdings following the recent reconstitution. Its index has a sector weight cap of 22% and an individual security weight cap of 2%. This provides diversified access to U.S. small-cap quality dividend payers. The fund focuses on high profitability and low leverage, effectively filtering out cyclical, debt-heavy segments of the market. This unique methodology means its index excludes the energy and real estate sectors and maintains minimal exposure to materials. Among the 28 additions to the portfolio, healthcare providers and technology enablers took center stage. Concentra Group Holdings Parent Inc (CON) and Universal Health Services Inc (UHS) entered as top additions. Industrials and fintech also gained representation through Graco Inc (GGG) and Jack Henry & Associates Inc (JKHY).Pruning Consumer Food Staples & Leveraged HoldingsA clear theme across the 26 deletions was the exit of low-margin or highly leveraged consumer staples and legacy food producers. Names like Conagra Brands Inc (CAG), The Wendy’s Company (WEN), Albertsons Companies Inc (ACI) were removed completely from the index. Additional deletions included legacy industrial and technology components such as ITT Inc (ITT) and TD Synnex Corp (SNX). For advisors seeking small-cap exposure without taking on speculative balance-sheet risk, OUSM’s methodology helps target profitable, stable companies, positioning the portfolio around resilient dividend payers. For more news, information, and analysis, visit the ETF Building Blocks Content Hub. VettaFi LLC (“VettaFi”) is the index provider for OUSM, for which it receives an index licensing fee. However, OUSM is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of OUSM.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.